US4577301090 - Common Stock
On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.
MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the...
The results also pressured ResMed, a maker of CPAPs. CPAPs are the common treatment for sleep apnea.
MINNEAPOLIS, April 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter...
MINNEAPOLIS, March 05, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the...
WHY: NEW YORK, NY - (NewMediaWire) - February 20, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
WHY: NEW YORK, NY - (NewMediaWire) - February 20, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. ("Inspire...
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. ("Inspire Medical" or the "Company")...
WHY: NEW YORK, NY - (NewMediaWire) - February 13, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. ("Inspire Medical" or the "Company") (NYSE: INSP) of a class action...
KeyBanc has resumed coverage of nearly a dozen medtech companies, with Inspire (INSP), Integer (ITGR) and ICU Medical (ICUI) as its top investment ideas. Read more here.
WHY: NEW YORK, NY - (NewMediaWire) - February 11, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP)...
/PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 20, 2024 to file lead plaintiff...
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. ("Inspire...
/PRNewswire/ -- Attention Inspire Medical Systems, Inc. ("Inspire Medical") (NYSE: INSP) shareholders: The Law Offices of Vincent Wong announce that a class...
/PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Inspire Medical Systems, Inc. (NYSE: INSP), if...
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. ("Inspire Medical" or the "Company")...
WHY: NEW YORK, NY - (NewMediaWire) - February 06, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
WHY: NEW YORK, NY - (NewMediaWire) - February 06, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between May 3, 2023 and November 7, 2023, both dates inclusive (the “Class Period”), of the important February 20, 2024 lead plaintiff deadline.
Inspire Reports First Quarter with Operating Income and Year-over-Year
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Inspire Medical Systems, Inc. ("Inspire Medical" or the "Company") (NYSE: INSP) of a class action...